Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen

Ho-Young Lim

Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen

Ho-Young Lim

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Blood Research
State	Published - 2022.03.31

Cite this

@article{42af9d774f3e4009a9d54b819995248b,

title = "Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen",

author = "Ho-Young Lim",

year = "2022",

month = mar,

day = "31",

language = "Korean",

journal = "Blood Research",

issn = "2287-979X",

}